Oncology

QIAGEN provides a broad portfolio of assays for clinical diagnosis, predictive companion diagnosis and for monitoring of disease. ...

Read more

QIAGEN provides a broad portfolio of assays for clinical diagnosis, predictive companion diagnosis and for monitoring of disease.

Better understanding of the genetic events that underlie cancer development and progression has led to improvements in patient healthcare. Using genetic biomarkers, it is now possible to identify individuals most likely to respond to a particular therapy and to follow up on treatment success.